Comprehensive Financial Consultants Institutional Inc. Acquires 220 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Comprehensive Financial Consultants Institutional Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,536 shares of the healthcare conglomerate’s stock after purchasing an additional 220 shares during the quarter. Comprehensive Financial Consultants Institutional Inc.’s holdings in UnitedHealth Group were worth $1,749,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in UnitedHealth Group by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock valued at $44,150,045,000 after acquiring an additional 250,291 shares during the period. Wellington Management Group LLP lifted its holdings in UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after buying an additional 527,526 shares during the period. Capital Research Global Investors increased its stake in shares of UnitedHealth Group by 2.2% in the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after buying an additional 324,733 shares during the period. Capital International Investors boosted its holdings in UnitedHealth Group by 4.8% in the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after acquiring an additional 542,424 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $5,802,231,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on UNH shares. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Robert W. Baird initiated coverage on UnitedHealth Group in a report on Thursday, May 30th. They issued an “outperform” rating and a $597.00 target price for the company. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective for the company in a research report on Wednesday, June 5th. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research report on Tuesday. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Stock Up 0.6 %

Shares of UNH stock traded up $2.78 on Tuesday, hitting $492.12. The stock had a trading volume of 3,056,843 shares, compared to its average volume of 4,255,447. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market cap of $452.94 billion, a price-to-earnings ratio of 30.08, a price-to-earnings-growth ratio of 1.44 and a beta of 0.60. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The business has a 50 day moving average of $498.64 and a 200 day moving average of $500.01.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the company posted $6.26 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.71%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.